|
| 36693944 | Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy. | NPJ Precis Oncol | 2023 |
| 37581937 | NLRP12 downregulates the Wnt/β-catenin pathway via interaction with STK38 to suppress colorectal cancer. | J Clin Invest | 2023 |
| 37502925 | Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. | Res Sq | 2023 |
| 37355762 | Critical role of antioxidant programs in enzalutamide-resistant prostate cancer. | Oncogene | 2023 |
| 35881485 | Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition. | JCI Insight | 2022 |
| 35349486 | Targeting radioresistance and replication fork stability in prostate cancer. | JCI Insight | 2022 |
| 35703180 | FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity. | J Clin Invest | 2022 |
| 36108240 | Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture. | Cancer Discov | 2022 |
| 32343676 | The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer. | J Clin Invest | 2020 |
| 32546840 | Prostate carcinogenesis: inflammatory storms. | Nat Rev Cancer | 2020 |
| 31591588 | Genome-wide germline correlates of the epigenetic landscape of prostate cancer. | Nat Med | 2019 |
| 31900904 | Genetic, Environmental, and Nuclear Factors Governing Genomic Rearrangements. | Adv Exp Med Biol | 2019 |
| 29346775 | BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer. | Cell Rep | 2018 |
| 29555663 | Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC). | Clin Cancer Res | 2018 |
| 28754673 | Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation. | Cancer Res | 2017 |
| 26908012 | Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer. | Nat Commun | 2016 |
| 26620415 | Functional Analysis of a Novel Connexin30 Mutation in a Large Family with Hearing Loss, Pesplanus, Ichthyosis, Cutaneous Nodules, and Keratoderma. | Ann Hum Genet | 2016 |
| 27926866 | Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer. | Cell Rep | 2016 |
| 25078033 | TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer. | Nat Commun | 2014 |
| 25058385 | The emerging role of speckle-type POZ protein (SPOP) in cancer development. | Drug Discov Today | 2014 |
| 24141370 | The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease. | Blood | 2013 |
| 22117046 | Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. | Blood | 2012 |
| 23097625 | Role of transcriptional corepressor CtBP1 in prostate cancer progression. | Neoplasia | 2012 |
| 21676887 | TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. | Cancer Res | 2011 |
| 21840484 | Coordinated regulation of polycomb group complexes through microRNAs in cancer. | Cancer Cell | 2011 |
| 21532618 | The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma. | Oncogene | 2011 |
| 20478527 | An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. | Cancer Cell | 2010 |
| 21045868 | Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences. | Nat Rev Genet | 2010 |
| 18941476 | Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss. | Eur J Hum Genet | 2009 |
| 19933109 | Induced chromosomal proximity and gene fusions in prostate cancer. | Science | 2009 |
| 19008416 | Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. | Science | 2008 |
| 18806826 | Repression of E-cadherin by the polycomb group protein EZH2 in cancer. | Oncogene | 2008 |